American Regent, Inc. recalls Levocarnitine Injection
- Published
- 6 May 2026
- Units affected
- 74,040 Single Dose Vials
- Agency
- FDA
- Country
- United States
The hazard
Labeling: Missing Label
Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC: 0517-1045-01
- Brand / company
- American Regent, Inc.
- Codes / lots
- Lot 24159N0C0, Exp. June 30, 2026 Lot 25193N0C0, Exp. July 31, 2027
- Distribution
- U.S. Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 6 May 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.